<DOC>
	<DOCNO>NCT02098772</DOCNO>
	<brief_summary>The objective investigation compare cardioprotective effect safety two cardioplegic solution , HTK Cardioplegic Solution ( Custodiol ) Custodiol-N patient undergo aortic valve surgery . The study design prospective , double blind , multicenter , randomize , Phase III comparison study intend demonstrate superiority surgical outcome Custodiol Custodiol-N determine CK-MB peak value 4-24 hour open aortic cross-clamp ( primary endpoint ) , catecholamine requirement ( cumulative dose ) cardiac Troponin T , occurrence comorbid event postoperatively ( e.g. , myocardial infarction ) .</brief_summary>
	<brief_title>Phase III Study Comparing Two Methods Cardioplegia Aortic Valve Surgery Custodiol-N Versus Custodiol</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Cardioplegic Solutions</mesh_term>
	<criteria>Patients &gt; /= 30 &lt; /= 85 year age Male female aortic valve disease Able understand character individual consequence clinical trial provide write informed consent participate study Women childbearing potential ( ie , undergone hysterectomy postmenopausal least 12 consecutive month ) must test negative pregnancy prior bypass surgery . History recent ( &lt; 6 week ) Qwave myocardial infarction Left ventricular ejection fraction &lt; 25 % ( assessed one following : contrast ventriculography , multigated acquisition scan [ MUGA ] , 2D ECHO ) Patients intraaortic balloon device history previous coronary artery bypass surgery Pregnant lactating patient Patients participate investigational study within 30 day previous enrollment Patients cardiogenic shock ( define systolic BP &lt; 90 mmHg one hour despite inotropic chronotropic support ) Patients severe chronic obstructive lung disease ( FEV1 &lt; 50 % ) Previous cardiac valvular disease ( clinical relevant ) GFR &lt; 60 ml/min Planned Rossprocedure , Mitral valve surgery , Aortic valve reconstruction , double valve surgery , concomitant operation exclude coronary artery bypass surgery closing patent foramen ovale Evidence severe organic ( e.g . cirrhosis liver ) psychiatric disease history physical examination History alcohol abuse , illicit drug use , significant mental illness , physical dependence opioid , history drug abuse addiction within 12 month study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>aortic valve disease</keyword>
	<keyword>coronary bypass surgery</keyword>
	<keyword>cardioplegic solution</keyword>
</DOC>